Chapter 11 Spatio-Temporal Dynamics of Phosphatidylinositol-3,4,5-Trisphosphate Signalling

Vitamins and Hormones

Volumn 80, Issue C, 2009, Pages 287-311

  Tengholm, Anders ^a   Idevall Hagren, Olof ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

fluorescence imaging; insulin secretion; oscillations; PH domain; PI3 kinase; PTEN; SHIP2

Indexed keywords

INSULIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5-TRIPHOSPHATE; POLYPHOSPHOINOSITIDE;

ANIMAL; HUMAN; METABOLISM; MOUSE; PANCREAS ISLET BETA CELL; PHYSIOLOGY; RAT; REVIEW; SIGNAL TRANSDUCTION; TIME;

ANIMALS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MICE; PHOSPHATIDYLINOSITOL PHOSPHATES; RATS; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 61349148800     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(08)00611-0     Document Type: Review

References (141)

1. Ananthanarayanan B., Ni Q., and Zhang J. Signal propagation from membrane messengers to nuclear effectors revealed by reporters of phosphoinositide dynamics and Akt activity. Proc. Natl. Acad. Sci. USA 102 (2005) 15081-15086
2. Arrieumerlou C., and Meyer T. A local coupling model and compass parameter for eukaryotic chemotaxis. Dev. Cell 8 (2005) 215-227
3. Ashcroft F.M., and Rorsman P. Electrophysiology of the pancreatic β-cell. Prog. Biophys. Mol. Biol. 54 (1989) 87-143
4. Aspinwall C.A., Lakey J.R., and Kennedy R.T. Insulin-stimulated insulin secretion in single pancreatic beta cells. J. Biol. Chem. 274 (1999) 6360-6365
5. Astle M.V., Seaton G., Davies E.M., Fedele C.G., Rahman P., Arsala L., and Mitchell C.A. Regulation of phosphoinositide signaling by the inositol polyphosphate 5-phosphatases. IUBMB Life 58 (2006) 451-456
6. Balla T., and Varnai P. Visualizing cellular phosphoinositide pools with GFP-fused protein-modules. Sci. STKE 2002 (2002) PL3
7. Berridge M.J., Lipp P., and Bootman M.D. The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell. Biol. 1 (2000) 11-21
8. Blero D., De Smedt F., Pesesse X., Paternotte N., Moreau C., Payrastre B., and Erneux C. The SH2 domain containing inositol 5-phosphatase SHIP2 controls phosphatidylinositol 3,4,5-trisphosphate levels in CHO-IR cells stimulated by insulin. Biochem. Biophys. Res. Commun. 282 (2001) 839-843
9. Borelli M.I., Francini F., and Gagliardino J.J. Autocrine regulation of glucose metabolism in pancreatic islets. Am. J. Physiol. Endocrinol. Metab. 286 (2004) E111-E115
10. Borodinsky L.N., and Spitzer N.C. Second messenger pas de deux: The coordinated dance between calcium and cAMP. Sci. STKE 2006 (2006) pe22
11. Butler M., McKay R.A., Popoff I.J., Gaarde W.A., Witchell D., Murray S.F., Dean N.M., Bhanot S., and Monia B.P. Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice. Diabetes 51 (2002) 1028-1034
12. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
13. 3 in cells. J. Histochem. Cytochem. 50 (2002) 697-708
14. Clement S., Krause U., Desmedt F., Tanti J.F., Behrends J., Pesesse X., Sasaki T., Penninger J., Doherty M., Malaisse W., Dumont J.E., Le Marchand-Brustel Y., et al. The lipid phosphatase SHIP2 controls insulin sensitivity. Nature 409 (2001) 92-97
15. 2+ oscillations and waves by oscillating translocation and activation of protein kinase C. Curr. Biol. 11 (2001) 1089-1097
16. Cooper D.M., Mons N., and Karpen J.W. Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature 374 (1995) 421-424
17. Costello P.S., Gallagher M., and Cantrell D.A. Sustained and dynamic inositol lipid metabolism inside and outside the immunological synapse. Nat. Immunol. 3 (2002) 1082-1089
18. Cox D., Berg J.S., Cammer M., Chinegwundoh J.O., Dale B.M., Cheney R.E., and Greenberg S. Myosin X is a downstream effector of PI(3)K during phagocytosis. Nat. Cell Biol. 4 (2002) 469-477
19. Da Silva Xavier G., Qian Q., Cullen P.J., and Rutter G.A. Distinct roles for insulin and insulin-like growth factor-1 receptors in pancreatic β-cell glucose sensing revealed by RNA silencing. Biochem. J. 377 (2004) 149-158
20. 2+ oscillations. Science 279 (1998) 227-230
21. 3 signaling: An ongoing story. J. Cell. Biochem. 98 (2006) 469-485
22. 2+ signalling in HL60 neutrophils. J. Cell Sci. 119 (2006) 443-451
23. 2+ response amplitude and duration. Nature 386 (1997) 855-858
24. Dolmetsch R.E., Xu K., and Lewis R.S. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 392 (1998) 933-936
25. Dyachok O., Isakov Y., Sågetorp J., and Tengholm A. Oscillations of cyclic AMP in hormone-stimulated insulin-secreting β-cells. Nature 439 (2006) 349-352
26. Dyachok O., Sågetorp J., Isakov Y., and Tengholm A. cAMP oscillations restrict protein kinase A redistribution in insulin-secreting cells. Biochem. Soc. Trans. 34 (2006) 498-501
27. Dyachok O., Idevall-Hagren O., Sågetorp J., Tian G., Wuttke A., Arrieumerlou C., Akusjärvi G., Gylfe E., and Tengholm A. Glucose-induced cyclic AMP oscillations regulate pulsatile insulin secretion. Cell Metab. 8 (2008) 26-37
28. Elahi D., Nagulesparan M., Hershcopf R.J., Muller D.C., Tobin J.D., Blix P.M., Rubenstein A.H., Unger R.H., and Andres R. Feedback inhibition of insulin secretion by insulin: Relation to the hyperinsulinemia of obesity. N. Engl. J. Med. 306 (1982) 1196-1202
29. Engelman J.A., Luo J., and Cantley L.C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 7 (2006) 606-619
30. 2+] elevation signals. Diabetes 51 (2002) 87-97
31. Foukas L.C., Claret M., Pearce W., Okkenhaug K., Meek S., Peskett E., Sancho S., Smith A.J., Withers D.J., and Vanhaesebroeck B. Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature 441 (2006) 366-370
32. Frech M., Andjelkovic M., Ingley E., Reddy K.K., Falck J.R., and Hemmings B.A. High affinity binding of inositol phosphates and phosphoinositides to the pleckstrin homology domain of RAC/protein kinase B and their influence on kinase activity. J. Biol. Chem. 272 (1997) 8474-8481
33. Funamoto S., Meili R., Lee S., Parry L., and Firtel R.A. Spatial and temporal regulation of 3-phosphoinositides by PI 3-kinase and PTEN mediates chemotaxis. Cell 109 (2002) 611-623
34. Gamper N., and Shapiro M.S. Regulation of ion transport proteins by membrane phosphoinositides. Nat. Rev. Neurosci. 8 (2007) 921-934
35. Gassama-Diagne A., Yu W., ter Beest M., Martin-Belmonte F., Kierbel A., Engel J., and Mostov K. Phosphatidylinositol-3,4,5-trisphosphate regulates the formation of the basolateral plasma membrane in epithelial cells. Nat. Cell Biol. 8 (2006) 963-970
36. 2+ in the pancreatic β-cell. Biochem. Biophys. Res. Commun. 151 (1988) 1299-1304
37. Gurung R., Tan A., Ooms L.M., McGrath M.J., Huysmans R.D., Munday A.D., Prescott M., Whisstock J.C., and Mitchell C.A. Identification of a novel domain in two mammalian inositol-polyphosphate 5-phosphatases that mediates membrane ruffle localization. The inositol 5-phosphatase skip localizes to the endoplasmic reticulum and translocates to membrane ruffles following epidermal growth factor stimulation. J. Biol. Chem. 278 (2003) 11376-11385
38. Gylfe E., Ahmed M., Bergsten P., Dansk H., Dyachok O., Eberhardson M., Grapengiesser E., Hellman B., Lin J.M., Sundsten T., Tengholm A., Vieira E., et al. Signaling underlying pulsatile insulin secretion. Ups. J. Med. Sci. 105 (2000) 35-51
39. Hafizi S., Ibraimi F., and Dahlbäck B. C1-TEN is a negative regulator of the Akt/PKB signal transduction pathway and inhibits cell survival, proliferation, and migration. FASEB J. 19 (2005) 971-973
40. Hagiwara S., Sakurai T., Tashiro F., Hashimoto Y., Matsuda Y., Nonomura Y., and Miyazaki J. An inhibitory role for phosphatidylinositol 3-kinase in insulin secretion from pancreatic B cell line MIN6. Biochem. Biophys. Res. Commun. 214 (1995) 51-59
41. 2-binding site on Kir6.2 by molecular modelling and functional analysis. EMBO J. 26 (2007) 3749-3759
42. Halet G. Imaging phosphoinositide dynamics using GFP-tagged protein domains. Biol. Cell 97 (2005) 501-518
43. 3 synthesis promotes the development and survival of early mammalian embryos. Development 135 (2008) 425-429
44. Harbeck M.C., Louie D.C., Howland J., Wolf B.A., and Rothenberg P.L. Expression of insulin receptor mRNA and insulin receptor substrate 1 in pancreatic islet beta-cells. Diabetes 45 (1996) 711-717
45. ATP) channels in rat CRI-G1 insulinoma cells involves disruption of the actin cytoskeleton. J. Physiol. 527 Pt. 1 (2000) 95-107
46. Haugh J.M., Codazzi F., Teruel M., and Meyer T. Spatial sensing in fibroblasts mediated by 3′ phosphoinositides. J. Cell Biol. 151 (2000) 1269-1280
47. Hawkins P.T., Anderson K.E., Davidson K., and Stephens L.R. Signalling through Class I PI3Ks in mammalian cells. Biochem. Soc. Trans. 34 (2006) 647-662
48. Henquin J.C. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49 (2000) 1751-1760
49. 2+ mobilization patterns. Science 284 (1999) 1527-1530
50. Holst L.S., Mulder H., Manganiello V., Sundler F., Ahren B., Holm C., and Degerman E. Protein kinase B is expressed in pancreatic β cells and activated upon stimulation with insulin-like growth factor I. Biochem. Biophys. Res. Commun. 250 (1998) 181-186
51. Hori H., Sasaoka T., Ishihara H., Wada T., Murakami S., Ishiki M., and Kobayashi M. Association of SH2-containing inositol phosphatase 2 with the insulin resistance of diabetic db/db mice. Diabetes 51 (2002) 2387-2394
52. Idevall-Hagren O., and Tengholm A. Glucose and insulin synergistically activate PI3-kinase to trigger oscillations of phosphatidylinositol-3,4,5-trisphosphate in β-cells. J. Biol. Chem. 281 (2006) 39121-39127
53. Iijima M., and Devreotes P. Tumor suppressor PTEN mediates sensing of chemoattractant gradients. Cell 109 (2002) 599-610
54. Ijuin T., and Takenawa T. SKIP negatively regulates insulin-induced GLUT4 translocation and membrane ruffle formation. Mol. Cell. Biol. 23 (2003) 1209-1220
55. Ishihara H., Sasaoka T., Hori H., Wada T., Hirai H., Haruta T., Langlois W.J., and Kobayashi M. Molecular cloning of rat SH2-containing inositol phosphatase 2 (SHIP2) and its role in the regulation of insulin signaling. Biochem. Biophys. Res. Commun. 260 (1999) 265-272
56. Itoh R.E., Kurokawa K., Ohba Y., Yoshizaki H., Mochizuki N., and Matsuda M. Activation of rac and cdc42 video imaged by fluorescent resonance energy transfer-based single-molecule probes in the membrane of living cells. Mol. Cell. Biol. 22 (2002) 6582-6591
57. Iversen J., and Miles D.W. Evidence for a feedback inhibition of insulin on insulin secretion in the isolated, perfused canine pancreas. Diabetes 20 (1971) 1-9
58. James S.R., Downes C.P., Gigg R., Grove S.J., Holmes A.B., and Alessi D.R. Specific binding of the Akt-1 protein kinase to phosphatidylinositol 3,4,5-trisphosphate without subsequent activation. Biochem. J. 315 Pt. 3 (1996) 709-713
59. Jimenez-Feltstrom J., Lundquist I., Obermuller S., and Salehi A. Insulin feedback actions: Complex effects involving isoforms of islet nitric oxide synthase. Regul. Pept. 122 (2004) 109-118
60. Kagawa S., Sasaoka T., Yaguchi S., Ishihara H., Tsuneki H., Murakami S., Fukui K., Wada T., Kobayashi S., Kimura I., and Kobayashi M. Impact of SRC homology 2-containing inositol 5′-phosphatase 2 gene polymorphisms detected in a Japanese population on insulin signaling. J. Clin. Endocrinol. Metab. 90 (2005) 2911-2919
61. Kagawa S., Soeda Y., Ishihara H., Oya T., Sasahara M., Yaguchi S., Oshita R., Wada T., Tsuneki H., and Sasaoka T. Impact of transgenic overexpression of SH2-containing inositol 5′-phosphatase 2 on glucose metabolism and insulin signaling in mice. Endocrinology 149 (2008) 642-650
62. + channels in pancreatic β-cells through a phosphatidylinositol 3-kinase-dependent pathway. Diabetes 50 (2001) 2192-2198
63. Knight Z.A., Gonzalez B., Feldman M.E., Zunder E.R., Goldenberg D.D., Williams O., Loewith R., Stokoe D., Balla A., Toth B., Balla T., Weiss W.A., et al. A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling. Cell 125 (2006) 733-747
64. Kontos C.D., Stauffer T.P., Yang W.P., York J.D., Huang L., Blanar M.A., Meyer T., and Peters K.G. Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol. Cell. Biol. 18 (1998) 4131-4140
65. Kulkarni R.N., Bruning J.C., Winnay J.N., Postic C., Magnuson M.A., and Kahn C.R. Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96 (1999) 329-339
66. Kulkarni R.N., Winnay J.N., Daniels M., Bruning J.C., Flier S.N., Hanahan D., and Kahn C.R. Altered function of insulin receptor substrate-1-deficient mouse islets and cultured β-cell lines. J. Clin. Invest. 104 (1999) R69-R75
67. Kunkel M.T., Ni Q., Tsien R.Y., Zhang J., and Newton A.C. Spatio-temporal dynamics of protein kinase B/Akt signaling revealed by a genetically encoded fluorescent reporter. J. Biol. Chem. 280 (2005) 5581-5587
68. Kurlawalla-Martinez C., Stiles B., Wang Y., Devaskar S.U., Kahn B.B., and Wu H. Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue. Mol. Cell. Biol. 25 (2005) 2498-2510
69. Lang D.A., Matthews D.R., Burnett M., and Turner R.C. Brief, irregular oscillations of basal plasma insulin and glucose concentrations in diabetic man. Diabetes 30 (1981) 435-439
70. Lawlor M.A., and Alessi D.R. PKB/Akt: A key mediator of cell proliferation, survival and insulin responses?. J. Cell Sci. 114 (2001) 2903-2910
71. Lazar D.F., and Saltiel A.R. Lipid phosphatases as drug discovery targets for type 2 diabetes. Nat. Rev. Drug Discov. 5 (2006) 333-342
72. Leibiger I.B., Leibiger B., Moede T., and Berggren P.O. Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase pathways. Mol. Cell 1 (1998) 933-938
73. Leibiger I.B., Leibiger B., and Berggren P.O. Insulin feedback action on pancreatic β-cell function. FEBS Lett. 532 (2002) 1-6
74. Lemmon M.A. Membrane recognition by phospholipid-binding domains. Nat. Rev. Mol. Cell. Biol. 9 (2008) 99-111
75. Maechler P., and Wollheim C.B. Mitochondrial function in normal and diabetic β-cells. Nature 414 (2001) 807-812
76. Maehama T., Taylor G.S., and Dixon J.E. PTEN and myotubularin: Novel phosphoinositide phosphatases. Annu. Rev. Biochem. 70 (2001) 247-279
77. Manning B.D., and Cantley L.C. AKT/PKB signaling: Navigating downstream. Cell 129 (2007) 1261-1274
78. Marion E., Kaisaki P.J., Pouillon V., Gueydan C., Levy J.C., Bodson A., Krzentowski G., Daubresse J.C., Mockel J., Behrends J., Servais G., Szpirer C., et al. The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man. Diabetes 51 (2002) 2012-2017
79. Marshall J.G., Booth J.W., Stambolic V., Mak T., Balla T., Schreiber A.D., Meyer T., and Grinstein S. Restricted accumulation of phosphatidylinositol 3-kinase products in a plasmalemmal subdomain during Fc gamma receptor-mediated phagocytosis. J. Cell Biol. 153 (2001) 1369-1380
80. Meili R., Ellsworth C., Lee S., Reddy T.B., Ma H., and Firtel R.A. Chemoattractant-mediated transient activation and membrane localization of Akt/PKB is required for efficient chemotaxis to cAMP in Dictyostelium. EMBO J. 18 (1999) 2092-2105
81. Mochizuki Y., and Takenawa T. Novel inositol polyphosphate 5-phosphatase localizes at membrane ruffles. J. Biol. Chem. 274 (1999) 36790-36795
82. Montero J.A., Kilian B., Chan J., Bayliss P.E., and Heisenberg C.P. Phosphoinositide 3-kinase is required for process outgrowth and cell polarization of gastrulating mesendodermal cells. Curr. Biol. 13 (2003) 1279-1289
83. Muller D., Huang G.C., Amiel S., Jones P.M., and Persaud S.J. Identification of insulin signaling elements in human β-cells: Autocrine regulation of insulin gene expression. Diabetes 55 (2006) 2835-2842
84. Myers Jr. M.G., and White M.F. Insulin signal transduction and the IRS proteins. Annu. Rev. Pharmacol. Toxicol. 36 (1996) 615-658
85. Nakashima N., Sharma P.M., Imamura T., Bookstein R., and Olefsky J.M. The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes. J. Biol. Chem. 275 (2000) 12889-12895
86. Neri L.M., Borgatti P., Capitani S., and Martelli A.M. The nuclear phosphoinositide 3-kinase/AKT pathway: A new second messenger system. Biochim. Biophys. Acta 1584 (2002) 73-80
87. 3 phosphatase SHIP1. Nat. Cell Biol. 9 (2007) 36-44
88. Nobes C.D., and Hall A. Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81 (1995) 53-62
89. + channel-dependent pathway in mouse islets and β-cells. Diabetes 53 (2004) 1765-1772
90. Oatey P.B., Venkateswarlu K., Williams A.G., Fletcher L.M., Foulstone E.J., Cullen P.J., and Tavare J.M. Confocal imaging of the subcellular distribution of phosphatidylinositol 3,4,5-trisphosphate in insulin- and PDGF-stimulated 3T3-L1 adipocytes. Biochem. J. 344 Pt. 2 (1999) 511-518
91. Ohsugi M., Cras-Meneur C., Zhou Y., Bernal-Mizrachi E., Johnson J.D., Luciani D.S., Polonsky K.S., and Permutt M.A. Reduced expression of the insulin receptor in mouse insulinoma (MIN6) cells reveals multiple roles of insulin signaling in gene expression, proliferation, insulin content, and secretion. J. Biol. Chem. 280 (2005) 4992-5003
92. Okada T., Liew C.W., Hu J., Hinault C., Michael M.D., Krtzfeldt J., Yin C., Holzenberger M., Stoffel M., and Kulkarni R.N. Insulin receptors in β-cells are critical for islet compensatory growth response to insulin resistance. Proc. Natl. Acad. Sci. USA 104 (2007) 8977-8982
93. Ono H., Katagiri H., Funaki M., Anai M., Inukai K., Fukushima Y., Sakoda H., Ogihara T., Onishi Y., Fujishiro M., Kikuchi M., Oka Y., et al. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes. Mol. Endocrinol. 15 (2001) 1411-1422
94. Ooms L.M., Fedele C.G., Astle M.V., Ivetac I., Cheung V., Pearson R.B., Layton M.J., Forrai A., Nandurkar H.H., and Mitchell C.A. The inositol polyphosphate 5-phosphatase, PIPP, Is a novel regulator of phosphoinositide 3-kinase-dependent neurite elongation. Mol. Biol. Cell 17 (2006) 607-622
95. O'Rahilly S., Turner R.C., and Matthews D.R. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N. Engl. J. Med. 318 (1988) 1225-1230
96. Parent C.A., Blacklock B.J., Froehlich W.M., Murphy D.B., and Devreotes P.N. G protein signaling events are activated at the leading edge of chemotactic cells. Cell 95 (1998) 81-91
97. Patel Y.C., Amherdt M., and Orci L. Quantitative electron microscopic autoradiography of insulin, glucagon, and somatostatin binding sites on islets. Science 217 (1982) 1155-1156
98. Persaud S.J., Asare-Anane H., and Jones P.M. Insulin receptor activation inhibits insulin secretion from human islets of Langerhans. FEBS Lett. 510 (2002) 225-228
99. Pesesse X., Deleu S., De Smedt F., Drayer L., and Erneux C. Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP. Biochem. Biophys. Res. Commun. 239 (1997) 697-700
100. ATP channel activation and leads to diet-sensitive obesity. J. Clin. Invest. 116 (2006) 1886-1901
101. Pørksen N. The in vivo regulation of pulsatile insulin secretion. Diabetologia 45 (2002) 3-20
102. 2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol. Rev. 67 (1987) 1185-1248
103. Rothenberg P.L., Willison L.D., Simon J., and Wolf B.A. Glucose-induced insulin receptor tyrosine phosphorylation in insulin-secreting beta-cells. Diabetes 44 (1995) 802-809
104. Rusten T.E., and Stenmark H. Analyzing phosphoinositides and their interacting proteins. Nat. Methods 3 (2006) 251-258
105. Rutter G.A. Insulin secretion: Feed-forward control of insulin biosynthesis?. Curr. Biol. 9 (1999) R443-R445
106. Saltiel A.R., and Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414 (2001) 799-806
107. Sarbassov D.D., Guertin D.A., Ali S.M., and Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307 (2005) 1098-1101
108. Sasaoka T., Wada T., Fukui K., Murakami S., Ishihara H., Suzuki R., Tobe K., Kadowaki T., and Kobayashi M. SH2-containing inositol phosphatase 2 predominantly regulates Akt2, and not Akt1, phosphorylation at the plasma membrane in response to insulin in 3T3-L1 adipocytes. J. Biol. Chem. 279 (2004) 14835-14843
109. 3 at endomembranes is triggered by receptor endocytosis. Nat. Cell Biol. 5 (2003) 1016-1022
110. Seo J.H., Ahn Y., Lee S.R., Yeol Yeo C., and Chung Hur K. The major target of the endogenously generated reactive oxygen species in response to insulin stimulation is phosphatase and tensin homolog and not phosphoinositide-3 kinase (PI-3 kinase) in the PI-3 kinase/Akt pathway. Mol. Biol. Cell 16 (2005) 348-357
111. Servant G., Weiner O.D., Herzmark P., Balla T., Sedat J.W., and Bourne H.R. Polarization of chemoattractant receptor signaling during neutrophil chemotaxis. Science 287 (2000) 1037-1040
112. Shepherd P.R., Withers D.J., and Siddle K. Phosphoinositide 3-kinase: The key switch mechanism in insulin signalling. Biochem. J. 333 Pt. 3 (1998) 471-490
113. ATP channels. Science 282 (1998) 1138-1141
114. Sleeman M.W., Wortley K.E., Lai K.M., Gowen L.C., Kintner J., Kline W.O., Garcia K., Stitt T.N., Yancopoulos G.D., Wiegand S.J., and Glass D.J. Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity. Nat. Med. 11 (2005) 199-205
115. Song J., Khachikian Z., Radhakrishna H., and Donaldson J.G. Localization of endogenous ARF6 to sites of cortical actin rearrangement and involvement of ARF6 in cell spreading. J. Cell Sci. 111 Pt. 15 (1998) 2257-2267
116. 3 and polarity during neutrophil chemotaxis. J. Cell Biol. 160 (2003) 375-385
117. Stiles B., Wang Y., Stahl A., Bassilian S., Lee W.P., Kim Y.J., Sherwin R., Devaskar S., Lesche R., Magnuson M.A., and Wu H. Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity. Proc. Natl. Acad. Sci. USA 101 (2004) 2082-2087
118. Tang X., Powelka A.M., Soriano N.A., Czech M.P., and Guilherme A. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes. J. Biol. Chem. 280 (2005) 22523-22529
119. Tengholm A., and Meyer T. A PI3-kinase signaling code for insulin-triggered insertion of glucose transporters into the plasma membrane. Curr. Biol. 12 (2002) 1871-1876
120. Tengholm A., Teruel M.N., and Meyer T. Single cell imaging of PI3K activity and glucose transporter insertion into the plasma membrane by dual color evanescent wave microscopy. Sci. STKE 2003 (2003) PL4
121. 2+ oscillation. EMBO J. 22 (2003) 3825-3832
122. Vanhaesebroeck B., Leevers S.J., Ahmadi K., Timms J., Katso R., Driscoll P.C., Woscholski R., Parker P.J., and Waterfield M.D. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70 (2001) 535-602
123. Van Schravendijk C.F., Foriers A., Van den Brande J.L., and Pipeleers D.G. Evidence for the presence of type I insulin-like growth factor receptors on rat pancreatic A and B cells. Endocrinology 121 (1987) 1784-1788
124. Varnai P., and Balla T. Live cell imaging of phosphoinositide dynamics with fluorescent protein domains. Biochim. Biophys. Acta 1761 (2006) 957-967
125. Varnai P., Rother K.I., and Balla T. Phosphatidylinositol 3-kinase-dependent membrane association of the Bruton's tyrosine kinase pleckstrin homology domain visualized in single living cells. J. Biol. Chem. 274 (1999) 10983-10989
126. Velloso L.A., Carneiro E.M., Crepaldi S.C., Boschero A.C., and Saad M.J. Glucose- and insulin-induced phosphorylation of the insulin receptor and its primary substrates IRS-1 and IRS-2 in rat pancreatic islets. FEBS Lett. 377 (1995) 353-357
127. Venkateswarlu K., Oatey P.B., Tavaré J.M., and Cullen P.J. Insulin-dependent translocation of ARNO to the plasma membrane of adipocytes requires phosphatidylinositol 3-kinase. Curr. Biol. 8 (1998) 463-466
128. Verspohl E.J., and Ammon H.P. Evidence for presence of insulin receptors in rat islets of Langerhans. J. Clin. Invest. 65 (1980) 1230-1237
129. Viard P., Butcher A.J., Halet G., Davies A., Nurnberg B., Heblich F., and Dolphin A.C. PI3K promotes voltage-dependent calcium channel trafficking to the plasma membrane. Nat. Neurosci. 7 (2004) 939-946
130. Wada T., Sasaoka T., Funaki M., Hori H., Murakami S., Ishiki M., Haruta T., Asano T., Ogawa W., Ishihara H., and Kobayashi M. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5′-phosphatase catalytic activity. Mol. Cell. Biol. 21 (2001) 1633-1646
131. Wang F., Herzmark P., Weiner O.D., Srinivasan S., Servant G., and Bourne H.R. Lipid products of PI(3)Ks maintain persistent cell polarity and directed motility in neutrophils. Nat. Cell Biol. 4 (2002) 513-518
132. Watton S.J., and Downward J. Akt/PKB localisation and 3′ phosphoinositide generation at sites of epithelial cell-matrix and cell-cell interaction. Curr. Biol. 9 (1999) 433-436
133. Westerlund J., Wolf B.A., and Bergsten P. Glucose-dependent promotion of insulin release from mouse pancreatic islets by the insulin-mimetic compound L-783,281. Diabetes 51 Suppl. 1 (2002) S50-S52
134. Wijesekara N., Konrad D., Eweida M., Jefferies C., Liadis N., Giacca A., Crackower M., Suzuki A., Mak T.W., Kahn C.R., Klip A., and Woo M. Muscle-specific Pten deletion protects against insulin resistance and diabetes. Mol. Cell. Biol. 25 (2005) 1135-1145
135. Withers D.J., Gutierrez J.S., Towery H., Burks D.J., Ren J.M., Previs S., Zhang Y., Bernal D., Pons S., Shulman G.I., Bonner-Weir S., and White M.F. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391 (1998) 900-904
136. Wu X., Senechal K., Neshat M.S., Whang Y.E., and Sawyers C.L. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. USA 95 (1998) 15587-15591
137. Xu G.G., and Rothenberg P.L. Insulin receptor signaling in the β-cell influences insulin gene expression and insulin content: Evidence for autocrine β-cell regulation. Diabetes 47 (1998) 1243-1252
138. 3 dynamics in EGF-stimulated carcinoma cells: A comparison of PH-domain-mediated methods with immunological methods. Biochem. J. 411 (2008) 441-448
139. Yoshizaki H., Ohba Y., Kurokawa K., Itoh R.E., Nakamura T., Mochizuki N., Nagashima K., and Matsuda M. Activity of Rho-family GTPases during cell division as visualized with FRET-based probes. J. Cell Biol. 162 (2003) 223-232
140. Yu W., O'Brien L.E., Wang F., Bourne H., Mostov K.E., and Zegers M.M. Hepatocyte growth factor switches orientation of polarity and mode of movement during morphogenesis of multicellular epithelial structures. Mol. Biol. Cell 14 (2003) 748-763
141. Zawalich W.S., and Zawalich K.C. A link between insulin resistance and hyperinsulinemia: Inhibitors of phosphatidylinositol 3-kinase augment glucose-induced insulin secretion from islets of lean, but not obese, rats. Endocrinology 141 (2000) 3287-3295